pharmaceutically controlled designer circuit
Multi-Component SwitchThe pharmaceutically controlled designer circuit is a synthetic multi-component signaling cascade activated by the clinically licensed antihypertensive drug guanabenz. In the reported system, guanabenz drives dose-dependent expression and secretion of a GLP-1-Fc(mIgG)-Leptin output relevant to metabolic syndrome treatment.